Reduction of Experimental Myocardial Infarct Size by Corticosteroid Administration

DSpace/Manakin Repository

Reduction of Experimental Myocardial Infarct Size by Corticosteroid Administration

Citable link to this page

 

 
Title: Reduction of Experimental Myocardial Infarct Size by Corticosteroid Administration
Author: Libby, Peter; Maroko, Peter R.; Bloor, Colin M.; Sobel, Burton E.; Braunwald, Eugene

Note: Order does not necessarily reflect citation order of authors.

Citation: Libby, Peter, Peter R. Maroko, Colin M. Bloor, Burton E. Sobel, and Eugene Braunwald. 1973. “Reduction of Experimental Myocardial Infarct Size by Corticosteroid Administration.” J. Clin. Invest. 52 (3) (March 1): 599–607. doi:10.1172/jci107221.
Full Text & Related Files:
Abstract: The influence of the administration of pharmacologic doses of hydrocortisone on the extent and severity of acute myocardial ischemic injury and on subsequent necrosis after acute coronary occlusion was investigated in 28 dogs. In order to study acute myocardial injury, repeated epicardial electrocardiograms were recorded from 10 to 15 sites on the anterior surface of the left ventricle. Average ST segment elevation (ST) and the number of sites in which ST segment elevation exceeded 2 mV (NST), indices of the magnitude and extent of myocardial injury, respectively, were analyzed at 30 and 60 min after coronary occlusion. In the control group ST and NST did not change significantly in this time interval while in the treated group, which received 50 mg/kg hydrocortisone just after the 30 min recording, ST fell from 3.5+/-0.8 to 1.1+/-0.4 mV (P 2 mV) in the control group showed histologic changes compatible with early myocardial infarction in 96% of specimens, while this occurred only in 61% and 63% of specimens, respectively, in the treated groups, showing that over one third of the sites were protected from undergoing necrosis due to the intervening hydrocortisone treatment. Thus pharmacological doses of hydrocortisone prevent myocardial cells from progressing to ischemic necrosis even when administration is initiated 6 h after coronary occlusion.
Published Version: doi:10.1172/JCI107221
Other Sources: http://www.ncbi.nlm.nih.gov/pubmed/4685084
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:13506941
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters